OxyContin maker cuts sales staff, won't hawk drug to docs

The decision by Purdue Pharma comes as the company battles an avalanche of lawsuits across the nation related to the opioid crisis.

     

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *